Skip to main content
SpringerLink
Log in

Ankylosing Spondylitis

Current Drug Treatment

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The administration of drugs constitutes an important component of the therapeutic programme in ankylosing spondylitis (AS). The main objective of initiating such therapy is to reduce pain, stiffness and discomfort.

There are at present 3 groups of drugs available for the management of AS. The first group is represented by drugs thought to influence the disease process itself. In this group, sulfasalazine is the only drug which in controlled trials has been shown to suppress disease activity in AS. We recommend the use of sulfasalazine in patients with high disease activity, with peripheral arthritis and in those with AS of short duration.

The second group of drugs includes nonsteroidal anti-inflammatory drugs (NSAIDs), which suppress inflammation without influencing the disease process. These drugs should be administered selectively during periods of high disease activity. Moreover, 1 drug should be used in appropriate dosage before it is assumed to be inefficient. High doses of NSAIDs may be prescribed before bedtime in patients suffering from severe pain and stiffness during the night. The toxicity profile of NSAIDs includes gastrointestinal and renal side effects.

The third group comprises analgesics and muscle relaxants. Such drugs should be used rather frequently in patients with longstanding AS refractory to treatment with NSAIDs.

Peripheral arthritis and enthesopathy are generally managed by local injections of corticosteroids, while AS complicated by psoriasis or inflammatory bowel disease is treated as primary AS. AS occurring in juveniles is best treated with aspirin and an NSAID, although careful observation is necessary for the development of Reye’s syndrome (with aspirin) and gastric irritation (with NSAIDs).

When patients with AS undergo surgery, the possibility of silent gastrointestinal bleeding due to the use of NSAIDs and salicylates should not be ignored. Patients treated with oral corticosteroids should receive a bolus injection of soluble corticosteroid prior to surgical intervention. NSAIDs may be administered pre- and postoperatively to relieve stiffness induced by immobility. Rapid treatment of intervening infections and use of NSAIDs is recommended in AS complicated by renal amyloidosis. During pregnancy and lactation, ibuprofen may be the preferred drug in AS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aabakken L, Bjørnbeth BA, Hofstad B, Olaussen B, Larsen S, et al. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric coated tablets and enteric coated granules in capsules. Scandinavian Journal of Gastroenterology 24 (Suppl. 163): 65–73, 1989

    Article  Google Scholar 

  • Aabakken L, Weberg R, Lygren I, Eidsvoll B, Stray N, et al. Gastrointestinal bleeding: dyspeptic symptoms and clinical course in relation to use of non-steroidal antiinflammatory drugs. Scandinavian Journal of Rheumatology 20: 366–369, 1991

    Article  PubMed  CAS  Google Scholar 

  • Alanso JCT, Perez AR, Castrillo JMA, Garcia JB, Noriega JRL, et al. Psosoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. British Journal of Rheumatology 30: 245–250, 1991

    Article  Google Scholar 

  • Amor B, Kahan A, Dougados M, Delrieu F. Sulphasalazine and ankylosing spondylitis. Annals of Internal Medicine 101: 878, 1984

    PubMed  CAS  Google Scholar 

  • Andrade LE, Atra E, Ferraz M. Sulphasalazine and ankylosing spondylitis: a pilot study. Clinical and Experimental Rheumatology 7: 661–662, 1989

    Google Scholar 

  • Ansell BM, Major G, Liyanage SP, Gumpel JM, Seifert MH, et al. A comparative study of butacote and naproxen in ankylosing spondylitis. Annals of the Rheumatic Diseases 37: 436–439, 1978

    Article  PubMed  CAS  Google Scholar 

  • Armstrong CP, Blower AL. Nonsteroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 28: 527–532, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bacon PA. An overview of the efficacy of etodolac in arthritic disorders. European Journal of Rheumatology and Inflammation 10: 22–34, 1990

    PubMed  CAS  Google Scholar 

  • Ball J. Enthesopathy of rheumatoid arthritis and ankylosing spondylitis. Annals of the Rheumatic Diseases 30: 213–223, 1971

    Article  PubMed  CAS  Google Scholar 

  • Bird HA, St Dixon A. Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA associated arthropathy. Annals of the Rheumatic Diseases 36: 289, 1977

    Article  PubMed  CAS  Google Scholar 

  • Black RL, O’Brian VM, van Scott EJ, Auerbach R, Eisen AZ, et al. Methotrexate therapy in psoriatic arthritis. Journal of the American Medical Association 189: 743–747, 1964

    Article  PubMed  CAS  Google Scholar 

  • Boersma JW. Retardation of ossification of lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scandinavian Journal of Rheumatology 5: 60–64, 1976

    PubMed  CAS  Google Scholar 

  • Bossingham DH, Schorn D, Morgan GW, Mowat AG. Progression of hip disease in rheumatoid arthritis. Rheumatology and Rehabilitation 17: 170–178, 1978

    Article  PubMed  CAS  Google Scholar 

  • Brater DC, Anderson S, Baird B, Campbell WB. Sulindac does not spare the kidney. Clinical Pharmacology and Therapy 35: 229, 1984

    Google Scholar 

  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, et al. Ankylosing spondylitis and HL-A27. Lancet 1: 904–907, 1973

    Article  PubMed  CAS  Google Scholar 

  • Brogden RN, Heel RC, Speight TM, Avery GS. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 16: 97–114, 1978

    Article  PubMed  CAS  Google Scholar 

  • Brpgden RN, Heel RC, Speight TH, Avery GS. Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy. Drugs 28: 292–323, 1984

    Google Scholar 

  • Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: differences and similarities. New England Journal of Medicine 324: 1716–1725, 1991

    Article  PubMed  CAS  Google Scholar 

  • Brooks PM, Kraag GR, Watson Buchanan W. Therapeutic implications of co-existing disorders. In Moll JMH (Ed.) Ankylosing spondylitis, pp. 187–213, Churchill Livingstone, Edinburgh, 1980

    Google Scholar 

  • Bunning RD, Barth WF. Sulindac: a potentially renal sparing nonsteroidal antiinflammatory drug. Journal of the American Medical Association 284: 2864–2867, 1982

    Article  Google Scholar 

  • Burry HC, Siebers R. A comparison of flurbiprofen with naproxen in ankylosing spondylitis. New Zealand Medical Journal 92: 309–311, 1980

    PubMed  CAS  Google Scholar 

  • Byron MA, Steele CE. A double-blind cross-over study comparing tolmetin sodium and naproxen In the treatment of ankylosing spondylitis. Current Medical Research and Opinions 7: 670–676, 1982

    Article  Google Scholar 

  • Calabro JJ. An appraisal of the medical and surgical management of ankylosing spondylitis. Clinical Orthopedics 60: 125–148, 1968

    Article  Google Scholar 

  • Calabro JJ. Management of ankylosing spondylitis. In Calabro JJ, Carson Dick W (Eds) Ankylosing spondylitis. New clinical applications in rheumatology, pp. 117–140, MTP Press Limited, Lancaster, 1987

    Google Scholar 

  • Calabro JJ, Amante CM. Indomethacin in ankylosing spondylitis. Arthritis and Rheumatism 11: 56–64, 1968

    Article  PubMed  CAS  Google Scholar 

  • Calin A, Grahame R. Double-blind cross-over trial of flurbiprofen and phenylbutazone in ankylosing spondylitis. British Medical Journal 4: 496–499, 1974

    Article  PubMed  CAS  Google Scholar 

  • Calin A, Elswood J. A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis. Journal of Rheumatology 17: 801–803, 1990

    PubMed  CAS  Google Scholar 

  • Caruso I, Bianchi-Porro G. Gastroscopic evaluation of antiinflammatory agents. British Medical Journal 280: 75–78, 1980

    Article  PubMed  CAS  Google Scholar 

  • Cassidy JT, Petty RE. Spondyloarthropathies. In Cassidy JT & Petty RE (Eds) Textbook of pediatric rheumatology, pp. 221–259, Churchill Livingstone, New York, 1990a

    Google Scholar 

  • Cassidy JT, Petty RE. Basic concepts of drug therapy. In Cassidy JT & Petty RE (Eds) Textbook of pediatric rheumatology, pp. 55–42, 93, Churchill Livingstone, New York, 1990b

    Google Scholar 

  • Cecere FA, Persellin RH. The interaction of pregnancy and the rheumatic diseases. Clinics in the Rheumatic Diseases 7: 747–768, 1981

    Google Scholar 

  • Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. New England Journal of Medicine 310: 279–283, 1984

    Article  PubMed  CAS  Google Scholar 

  • Christiansen J, Soos. Iatrogen caput femoris nekrose og indometacinbehandling. Ugeskrift for Laeger 143: 2153–2154, 1981

    PubMed  CAS  Google Scholar 

  • Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine 310: 563–572, 1984

    Article  PubMed  CAS  Google Scholar 

  • Corkill MM, Jobanputra P, Gibson T, Macfarlane DG. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect. British Journal of Rheumatology 29: 41–45, 1990

    Article  PubMed  CAS  Google Scholar 

  • Cove-Smith JR, Knapp MS. Analgesic nephropathy: an important cause of chronic renal failure. Quarterly Journal of Medicine 47: 49–69, 1978

    PubMed  CAS  Google Scholar 

  • Crompton GK, Cameron SJ, Langlands AO. Pulmonary fibrosis, pulmonary tuberculosis and ankylosing spondylitis. British Journal of Diseases of the Chest 68: 51–56, 1974

    Article  PubMed  CAS  Google Scholar 

  • Davis MJ, Dawes PT, Beswick E, Lewin IV, Stanworth DR. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A, and the complex immunoglobulin A-alpha-1-antitrypsin. British Journal of Rheumatology 28: 410–413, 1989

    Article  PubMed  CAS  Google Scholar 

  • Delee J, Ferrari A, Charnley J. Ectopic bone formation after low friction arthroplasty of the hip. Clinics in Orthopedics and Related Research 121: 53–59, 1976

    Google Scholar 

  • Dick AP, Grayson MJ, Carpenter RG, Petrie A. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5: 437–442, 1964

    Article  PubMed  CAS  Google Scholar 

  • Dorfmann H, de Seze S. Resultats d’-un essai controle du 19583 RP dans la pelveospondylite rheumatismale. Revue de Rhumatologie 40(b): 447–450, 1973

    CAS  Google Scholar 

  • Dougados M, Boumier P, Amor B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. British Medical Journal 293: 911–914, 1986

    Article  PubMed  CAS  Google Scholar 

  • Eberl R. Preliminary results with a new non-steroidal antiinflammatory agent, sulindac (MK-231), compared to phenylbutazone in the treatment of ankylosing spondylitis. Scandinavian Journal of Rheumatology 4 (Suppl. 8): S04–S05, 1974

    Google Scholar 

  • Ebringer R, Cawdell D, Ebringer A. Klebsiella pneumoniae and acute anterior uveitis in ankylosing spondylitis. British Medical Journal 1: 383, 1979

    Article  PubMed  CAS  Google Scholar 

  • Esdaile J, Rothwell R, MacLaughlin K, Percy J, Hawkins D. Double blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis. Journal of Rheumatology 9: 69–74, 1982

    PubMed  CAS  Google Scholar 

  • Farah D, Sturrock RD, Russell RI. Peptic ulcer in rheumatoid arthritis. Annals of the Rheumatic Diseases 47: 478–480, 1988

    Article  PubMed  CAS  Google Scholar 

  • Feltelius N, Hellgren R. Sulphasalazine in ankylosing spondylitis. Annals of the Rheumatic Diseases 45: 396–399, 1986

    Article  PubMed  CAS  Google Scholar 

  • Fernandez-Herlihy L. The articular manifestations of chronic ulcerative colitis. New England Journal of Medicine 261: 259–263, 1959

    Article  PubMed  CAS  Google Scholar 

  • Ferraz MB, da Silva HC, Atra E. Low dose methotrexate with leucovirin rescue in ankylosing spondylitis. Journal of Rheumatology 18: 146–147, 1991

    PubMed  CAS  Google Scholar 

  • Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Meta-analysis of sulphasalazine in ankylosing spondylitis. Journal of Rheumatology 17: 1482–1486, 1990

    PubMed  CAS  Google Scholar 

  • Fowler PD. Voltarol: diclofenac sodium. Clinics in the Rheumatic Diseases 5: 427–464, 1979

    Google Scholar 

  • Fraser SM, Sturrock RD. Evaluation of sulphasalazine in ankylosing spondylitis — an interventional study. British Journal of Rheumatology 29: 37–39, 1990

    Article  PubMed  CAS  Google Scholar 

  • Fries JF, Williams CA, Bloch DA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. American Journal of Medicine 91: 213–222, 1991

    Article  PubMed  CAS  Google Scholar 

  • Gengos D, Pingeon RA, Andrew A. Long-term comparison of sulindac and phenylbutazone for treatment of ankylosing spondylitis. Postgraduate Medical Communications (special report): 51-60, 1979

  • Gibson T, Laurent R. Sulindac and indomethacin in the treatment of ankylosing spondylitis: a double blind cross-over study. Rheumatology and Rehabilitation 19: 189–192, 1980

    Article  PubMed  CAS  Google Scholar 

  • Giercksky KE, Husby G, Rugstad HE. Epidemiology of NSAID induced gastrointestinal problems and the role of cimetidine in their prevention. Alimentary Pharmacology and Therapy 2 (Suppl. 1): 33–41, 1988

    Google Scholar 

  • Golding DN. D-penicillamine in ankylosing spondylitis and polymyositis. Postgraduate Medical Journal (Suppl.): 62, 1974

  • Good A, Mena H. Treatment of ankylosing spondylitis with flurbiprofen and indomethacin. Current Medical Research and Opinions 5: 117–121, 1977

    Article  CAS  Google Scholar 

  • Graham DY. What are the differences between NSAID related and other peptic ulcers. New Standards in Arthritis Care 2: 12, 1991

    Google Scholar 

  • Graham DY, Agrawal N, Roth SH. Prevention of NSAID-induced gastric ulcer with the synthetic prostaglandin misoprostol — a multicenter double-blind, placebo-controlled trial. Lancet 2: 1277–1280, 1989

    Google Scholar 

  • Gran JT. A clinical, radiological and epidemiological survey of ankylosing spondylitis. Thesis, University of Tromsø, Tromsø, 1985

  • Gran JT, Hordvik M, Husby G. Roentgenological features of ankylosing spondylitis. A comparison between patients attending hospital and cases selected through an epidemiological survey. Clinical Rheumatology 3: 467–472, 1984

    CAS  Google Scholar 

  • Gran JT, Husby G. Ankylosing spondylitis. A comparative study of patients found in an epidemiological survey and those admitted to a department of rheumatology. Journal of Rheumatology 11: 788–793, 1984

    CAS  Google Scholar 

  • Gran JT, Husby G. Ankylosing spondylitis in females. Seminars in Arthritis and Rheumatism 19: 303–312, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of TromsOnorthern Norway. Annals of the Rheumatic Diseases 44: 359–367, 1985

    Article  PubMed  CAS  Google Scholar 

  • Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. Part I: Pathophysiological aspects, ulcerative colitis and Crohn’s disease. Clinics in Digestive Diseases, in press, 1992b

  • Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Seminars in Arthritis and Rheumatism, submitted, 1992a

  • Grasedyck K, Schattenkirchner M, Bandilla K. Zur Behandlung der Spondylitis ankylosans mit Auranofin (’Ridaura’). Zeitschrift der Rheumatologie 49: 98–99, 1990

    CAS  Google Scholar 

  • Grill V, Smith M, Ahern M, Littlejohn G. Local radiotherapy for pedal manifestations of HLA B27 related arthropathy. British Journal of Rheumatology 27: 390–392, 1988

    Article  PubMed  CAS  Google Scholar 

  • Gueller R. Die Nebenwirkungen nicht-steroidaler Antirheumatika im unseren Gastrointestinaltrakt. Schweizerischer Medisinsche Wissenschaft 117: 1527–1523, 1987

    Google Scholar 

  • Handler RP. Favourable results using methotrexate in the treatment of patients with ankylosing spondylitis. Arthritis and Rheumatism 32: 234, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hart FD. Clinical features and complications. In Moll JMH (Ed.) Ankylosing spondylitis, pp. 52–68, Churchill Livingstone, Edinburgh, 1980

    Google Scholar 

  • Hartmann A, Holdaas H, Fauchald P. Fifteen years of experience with renal transplantation in systemic amyloidosis. Kidney International, in press, 1992

  • Hill AGS. Drug therapy. In Moll JMH (Ed.) Ankylosing spondylitis, pp. 163–175, Churchill Livingstone, Edinburgh, 1980

    Google Scholar 

  • Husby G. Amyloidosis in ankylosing spondylitis. Scandinavian Journal of Rheumatology 32 (Suppl.): 67–70, 1980

    Google Scholar 

  • Husby G. Amyloidosis. Seminars an Arthritis and Rheumatism, in press, 1992

  • Husby G, Holme I, Rugstad HE, Herland OB, Giercksky KE. A double blind multicenter trial of piroxicam and naproxen in osteoarthritis. Clinical Rheumatology 5: 84–91, 1986

    Article  PubMed  CAS  Google Scholar 

  • Husby G, Kass E, Spongsveen KL. Comparative double-blind trial of intra-articular injections of two long-acting forms of beta-methasone. Scandinavian Journal of Rheumatology 4: 118–120, 1975

    Article  PubMed  CAS  Google Scholar 

  • Husby G, Østensen M, Gran JT. Ankylosing spondylitis and pregnancy. Clinical and Experimental Rheumatology 6: 165–167, 1988

    PubMed  CAS  Google Scholar 

  • Husserl FE, Lange RK, Kantrow CM. Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. Journal of the American Medical Association 242: 1896–1898, 1979

    Article  PubMed  CAS  Google Scholar 

  • Jaffe IA. Penicillamine in seronegative polyarthritis. Annals of the Rheumatic Diseases 36: 593–594, 1977

    Article  PubMed  CAS  Google Scholar 

  • Jessop JD. Double blind study of ketoprofen and phenylbutazone in ankylosing spondylitis. Rheumatology and Rehabilitation 15 (Suppl.): 37–42, 1976

    Article  Google Scholar 

  • Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly. Part I. Drugs & Aging 1: 130–143, 1991

    Article  CAS  Google Scholar 

  • Jones E, Jones V, Woodbury JFL. Response to sulphasalazine in rheumatoid arthritis: a life-table analysis of a 5-year follow up. Journal of Rheumatology 18: 195–198, 1991

    PubMed  CAS  Google Scholar 

  • Jorde R, Burhol PG. Asymptomatic peptic ulcer disease. Gut 22: 129–134, 1987

    CAS  Google Scholar 

  • Juby A, Davis P. NSAID induced gastropathy. Journal of Rheumatology 18: 146, 1991

    PubMed  CAS  Google Scholar 

  • Kantor TG. Ibuprofen. Annals of Internal Medicine 91: 877–882, 1979

    PubMed  CAS  Google Scholar 

  • Khan MA. A double blind comparison of diclofenac and indometacine in the treatment of ankylosing spondylitis. Journal of Rheumatology 14: 118–123, 1987

    PubMed  CAS  Google Scholar 

  • Khan MA, van der Linden SM. Ankylosing spondylitis and other spondyloarthropathies. Rheumatic Diseases in Clinics of North America 6: 551–579, 1990

    Google Scholar 

  • Kinsella TD, Mackenzie KR, Kim SO, Johnson LG. Evaluation of indomethacin by a controlled, cross-over technique in 30 patients with ankylosing spondylitis. Canadian Medical Association Journal 67: 1454–1459, 1967

    Google Scholar 

  • Lance NJ, Curran JJ. Amyloidosis in a case of ankylosing spondylitis with a review of the literature. Journal of Rheumatology 18: 100–103, 1991

    PubMed  CAS  Google Scholar 

  • Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other nonsteroidal antiinflammatory agents. American Journal of Medicine 77: 19–24, 1984

    Article  PubMed  CAS  Google Scholar 

  • Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. American Journal of Gastroenterology 82: 1153–1158, 1987

    PubMed  CAS  Google Scholar 

  • Larkai EN, Smith JL, Lidsky MD, Sessoms SL, Graham DY. Dyspepsia in NSAID users: the size of the problem. Journal of Clinical Gastroenterology 11: 158–162, 1989

    Article  PubMed  CAS  Google Scholar 

  • Leca A, Camus JP. Spondylarthrite ankylosante echee du traitment par la D-penicillamine. Nouvelle Presse Medicale 4: 112, 1975

    CAS  Google Scholar 

  • Lennard Jones JE. Sulphasalazine, corticosteroids and immunosuppressive drugs in the treatment of Crohn’s disease. In Allan RN et al. (Eds) Inflammatory bowel disease, pp. 418–427, Churchill Livingstone, Edinburgh, 1983

    Google Scholar 

  • Liebling MR, Altman RD, Benedek TG, Bennahum DA, Blaschke JA, et al. A double-blind multiclinic trial of sulindac (MG-213) in the treatment of ankylosing spondylitis. Arthritis and Rheumatism 18: 411, 1975

    Google Scholar 

  • Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. American Journal of Medicine 77: 893–898, 1984

    Article  PubMed  CAS  Google Scholar 

  • Lomen PL, Turner LP, Lamborn KR, Bruin EL. Flurbiprofen in the treatment of ankylosing spondylitis: a comparison with indometacin. American Journal of Medicine 80: 127–132, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lussier A, de Medicis R. Correlation between ossification and inflammation using a rat experimental model. Journal of Rheumatology 10 (Suppl. 11): 114–117, 1983

    CAS  Google Scholar 

  • Mayrhofer F, Broell H, Eberl W, Klein G, Rainer F, et al. Tenoxicam versus diclofenac in patients with ankylosing spondylitis. Drug Investigation 2 (Suppl. 3): 52–53, 1990

    Article  Google Scholar 

  • McConkey B, Amos RS, Durham S, Forster PJS, Hubball S, et al. Sulphasalazine in rheumatoid arthritis. British Medical Journal 280: 442–444, 1980

    Article  PubMed  CAS  Google Scholar 

  • McKenzie SA, Selley JA, Agnew JE. Secretion of prednisolone into breast milk. Archives of Diseases of the Children 50: 894–896, 1975

    Article  CAS  Google Scholar 

  • Mielants H, Veys E. HLA-B27 related arthritis and bowel inflammation. Journal of Rheumatology 12: 287–293, 1985

    PubMed  CAS  Google Scholar 

  • Mielants H, Veys E, Joo R. Sulphasalazine (’salazopyrin’) in the treatment of enteric reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clinical Rheumatology 5: 80–83, 1986

    Article  PubMed  CAS  Google Scholar 

  • Mielants H, Veys EM. The gut in the spondyloarthropathies. Journal of Rheumatology 17: 7–10, 1990

    PubMed  CAS  Google Scholar 

  • Miller TA, Jacobson ED. Gastrointestinal cytoprotection by prostaglandins. Gut 20: 75–87, 1979

    Article  PubMed  CAS  Google Scholar 

  • Minz G, Enriquez RD, Mercado U. Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis. Arthritis and Rheumatism 24: 734–736, 1981

    Article  Google Scholar 

  • Nahir AR, Scharf Y. Comparative study of diclofenac and sulindac in ankylosing spondylitis. Rheumatology and Rehabilitation 19: 193–198, 1980

    Article  Google Scholar 

  • Neumann VC, Grindulis KA. Sulphasalazine in rheumatoid arthritis: an old drug reviewed. Journal of the Royal Society of Medicine 77: 169–172, 1984

    PubMed  CAS  Google Scholar 

  • Neumann VC, Wright V. Arthritis associated with bowel disease. Clinical Gastroenterology 12: 767–795, 1983

    CAS  Google Scholar 

  • Neustadt DH. Ankylosing spondylitis. Postgraduate Medicine 61: 124–135, 1977

    PubMed  CAS  Google Scholar 

  • Nicolic J, Lukacevic D. Ibuprofen (’Brufen’) in the treatment of ankylosing spondylitis. Current Medical Research and Opinions 3: 573–575, 1975

    Article  Google Scholar 

  • Nissile M. Use of osmic acid in the topical treatment of exudative synovitis of knee joint. Scandinavian Journal of Rheumatology (Suppl. 29): 1-5, 1978

    Google Scholar 

  • Nissile M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yll-Kerttula U. Sulphasalazine in the treatment of ankylosing spondylitis. Arthritis and Rheumatism 31: 1111–1116, 1988

    Article  Google Scholar 

  • Nollen AJG, Slooff TJJH. Pararticular ossifications after total hip replacement. Acta Orthopedica Scandinavica 44: 230–241, 1973

    Article  CAS  Google Scholar 

  • Nygaard H, Gran JT, Brath HK. Bivirkninger ved methylprednisolon terapi for revmatiske sykdommer. Tidsskrift for den Norske Laegeforening 107: 31–32, 1987

    PubMed  CAS  Google Scholar 

  • Østensen M, Husby G. A prospective clinical study of the effects of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis and Rheumatism 26: 1155–1159, 1983

    Article  PubMed  Google Scholar 

  • Østensen M, Husby G. Antirheumatic drug treatment during pregnancy and lactation. Scandinavian Journal of Rheumatology 14: 1–7, 1985

    Article  PubMed  Google Scholar 

  • Østensen M. Anti-rheumatic medication during pregnancy and lactation. Eular Bulletin 4: 131–134, 1985

    Google Scholar 

  • Peliskova Z, Vacha J, Trnavsky K. Sulphasalazine in reactive arthritis: an open trial. British Journal of Rheumatology 25 (Suppl. 2): Abstract 49, 1986

  • Peter E. A double blind comparison of naproxen and indomethacine on the aftermidnight pain of patients with morbus Bechterew. Arzneimittelforschnung 25: 324–325, 1975

    CAS  Google Scholar 

  • Pinals RS. Sulphasalazine in the rheumatic diseases. Seminars in Arthritis and Rheumatism 17: 246–259, 1988

    Article  PubMed  CAS  Google Scholar 

  • Richter MB. Management of the seronegative spondyloarthropathies. Clinics in the Rheumatic Diseases 11: 147–169, 1985

    CAS  Google Scholar 

  • Richter MB, Woo P, Panayi GS. The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis. Clinical and Experimental Rheumatology 53: 51–59, 1983

    CAS  Google Scholar 

  • Roberts DG, Gerber JG, Nies AS. Comparative effects of sulindac and indomethacin in humans. Clinical Pharmacology and Therapies 35: 269, 1984

    Google Scholar 

  • Robinson HS, Bradley EJ. The rehabilitation center and rheumatic diseases. Canadian Medical Association Journal 77: 131–133, 1957

    PubMed  CAS  Google Scholar 

  • Scharf Y, Nahir M. Penicillamine in ankylosing spondylitis. Arthritis and Rheumatism 19: 122, 1976

    Article  PubMed  CAS  Google Scholar 

  • Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, w27, with ankylosing spondylitis. New England Journal of Medicine 288: 704–706, 1973

    Article  PubMed  CAS  Google Scholar 

  • Scully CJ, Anderson CJ, Cannon GW. Long-term methotrexate therapy for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 20: 317–331, 1991

    Article  PubMed  CAS  Google Scholar 

  • Sharp J, Purser DW. Spontaneous atlanto-axial subluxation in ankylosing spondylitis and rheumatoid arthritis. Annals of the Rheumatic Diseases 20: 47, 1961

    Article  PubMed  CAS  Google Scholar 

  • Shipley M, Berry H, Bloom B. A double blind cross-over trial of indomethacin, fenoprofen and placebo in ankylosing spondylitis with comments on patient assessment. Rheumatology and Rehabilitation 19: 122–125, 1980

    Article  PubMed  CAS  Google Scholar 

  • Small RE. Diclofenac sodium. Clinical Pharmacology 8: 545–558, 1989

    CAS  Google Scholar 

  • Steven MM, Morrison M, Sturrock RD. Penicillamine in anky-losing spondylitis: a double blind placebo controlled trial. Journal of Rheumatology 12: 735–737, 1985

    PubMed  CAS  Google Scholar 

  • Stock KP, Bach GL. Peptic ulcer healing under treatment with ranitidin and antacids despite continued treatment with NSAID. Zeitschrift fur Rheumatologie 47: 177–181, 1988

    PubMed  CAS  Google Scholar 

  • Stuart MJ, Gross SJ, Eldrad H, Graeber JE. Effects of acetylsalicylic acid on maternal and neonatal hemostasis. New England Journal of Medicine 307: 909–912, 1982

    Article  PubMed  CAS  Google Scholar 

  • Stubbs DF, Freeman BE. Efficacy comparisons of flurbiprofen and other nonsteroidal anti-inflammatory drugs in arthritic diseases. Current Therapeutic Research 46: 511–528, 1989

    Google Scholar 

  • Sturrock RD, Hart FD. Double-blind cross-over comparison of indomethacin, flurbiprofen and placebo in ankylosing spondylitis. Annals of the Rheumatic Diseases 33: 129–131, 1974

    Article  PubMed  CAS  Google Scholar 

  • Sydnes OA. Comparison of piroxicam with indomethacin in ankylosing spondylitis. British Journal of Clinical Practice 35: 40–44, 1981

    PubMed  CAS  Google Scholar 

  • Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G, Pieton R. Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen. British Medical Journal 2: 231–232, 1977

    Article  PubMed  CAS  Google Scholar 

  • Tannenbaum H, DeCoteau WE, Esdaile JM, Ryan JP. A double blind multicenter trial comparing piroxicam and indomethacin in ankylosing spondylitis with long-term follow-up. Current Therapy and Research 36: 426–435, 1984

    Google Scholar 

  • Taylor HG, Beswick EJ, Dawes PT. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory asessment. Clinical Rheumatology 10: 43–48, 1991

    CAS  Google Scholar 

  • Treadwell BLJ, Tweed JM. Ketoprofen (’Orudis’) in ankylosing spondylitis. New Zealand Medical Journal 81: 411–413, 1975

    PubMed  CAS  Google Scholar 

  • Tytman K, Bernacka K, Sierakowski S. D-penicillamine in the therapy of ankylosing spondylitis. Clinical Rheumatology 8: 419–420, 1989

    Article  PubMed  CAS  Google Scholar 

  • van Gerwen F, van der Korst JK, Gribnau FWJ. Double blind trial of naproxen and phenylbutazone in ankylosing spondylitis. Annals of the Rheumatic Diseases 37: 85–88, 1978

    Article  PubMed  Google Scholar 

  • Walan A, Bader JP, Classen M. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. New England Journal of Medicine 320: 69–75, 1989

    Article  PubMed  CAS  Google Scholar 

  • Wasner C, Britton MC, Kraines RG, Kaye RL, Bobrove AM, et al. Nonsteroidal antiinflammatory agents in rheumatoid arthritis and ankylosing spondylitis. Journal of the American Medical Association 246: 2168–2172, 1981

    Article  PubMed  CAS  Google Scholar 

  • Wordsworth BP, Ebringer RW, Coggins E, Smith S. Double blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis. Rheumatology and Rehabilitation 19: 260–263, 1980

    Article  PubMed  CAS  Google Scholar 

  • Wright V. Arthropathia psoriatica — a clinical entity? Scandinavian Journal of Rheumatology 32 (Suppl.): 25–29, 1980

    Google Scholar 

  • Wynn-Parry CB, Deary J. Physical measures in rehabilitation. In Moll JMH (Ed.) Ankylosing spondylitis, pp. 214–226, Curchill Livingstone, Edinburgh, 1980

    Google Scholar 

  • Zeidler VH, Kalden J, Josenhans G. Klinische ergebnisse einer doppelprufung von Naproxen im vergleich zu Indomethacine bei chronischer polyartritis, spondylitis ankylopoietica und artrosen. Arzneimittel-Forschnung 25: 315–318, 1975

    Google Scholar 

  • Zurier RB. SLE and pregnancy. In Schur PH (Ed) The clinical management of systemic lupus erythematosus, pp. 211–220, Grune & Stratton, Orlando, Florida, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Central Hospital of Aust-Agder, 4800, Arendal, Norway

    Jan Tore Gran & Gunnar Husby

  2. Department of Rheumatology, Deakon’s Hospital, Oslo, Norway

    Jan Tore Gran & Gunnar Husby

Authors
  1. Jan Tore Gran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunnar Husby
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gran, J.T., Husby, G. Ankylosing Spondylitis. Drugs 44, 585–603 (1992). https://doi.org/10.2165/00003495-199244040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199244040-00006

Keywords

Search

Navigation